Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

LLyell Immunopharma, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
L

Lyell Immunopharma, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • History
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • History
  • Insider Transactions

Insider transactions

Insider sentiment

SellBuy
DateNameTitleSharesValueTransactionSource
Sep 10, 2026Shook DavidChief Medical Officer500Common Stock—Sell
Sep 10, 2026Aguirre Jarrad MattieuChief Medical Officer47,500Option (right to buy)—Grant / award
Aug 21, 2026Seely LynnPresident and CEO9,589Common Stock—Sell
Aug 21, 2026Hill Stephen J.Chief Operating Officer989Common Stock—Sell
Aug 21, 2026Lee Gary K.Chief Scientific Officer1,457Common Stock—Sell
Aug 10, 2026Seely LynnPresident and CEO390Common Stock—Sell
Aug 10, 2026Hill Stephen J.Chief Operating Officer89Common Stock—Sell
Aug 10, 2026Lee Gary K.Chief Scientific Officer131Common Stock—Sell
Aug 10, 2026Bulis Veronica SanchezVP, Corporate Controller621Common Stock—Sell
Jul 27, 2026Innovative Cellular Therapeutics Holdings Ltd10% Owner82,500Common Stock—Other
…